These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants. Wood S J Med; 1974; 5(1):7-22. PubMed ID: 4134042 [No Abstract] [Full Text] [Related]
3. The rationale of anticoagulants in the treatment of cancer. Cliffton EE; Grossi CE J Med; 1974; 5(1):107-13. PubMed ID: 4275504 [No Abstract] [Full Text] [Related]
4. The effect of heparin and warfarin on primary and metastatic tumors. Millar RC; Ketcham AS J Med; 1974; 5(1):23-31. PubMed ID: 4598770 [No Abstract] [Full Text] [Related]
5. [Metastasis occurrence, prophylaxis and tumor management with enzymes from the viewpoint of the gynecologist]. Stojanow G Osterr Z Erforsch Bekampf Krebskr; 1970; 25(5):355-63. PubMed ID: 5536491 [No Abstract] [Full Text] [Related]
7. Clinical studies with anticoagulants to improve survival in cancer patients. Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993 [TBL] [Abstract][Full Text] [Related]
8. Fibrin and cancer. Br Med J; 1971 Dec; 4(5788):641-2. PubMed ID: 5134558 [No Abstract] [Full Text] [Related]
9. [Clinical studies on activators and inhibitors of fibrinolysis in various internal diseases]. Smolenski WS; Bokarew IN; Jerschow WI; Mindlina GI Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):138-41. PubMed ID: 4134263 [No Abstract] [Full Text] [Related]
10. Use of alpha-adrenoceptor antagonist dihydroergotoxin in experimental anticoagulant and fibrinolytic therapy. Kalishevskaya TM; Golubeva MG; Bashkov GV Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):157-61. PubMed ID: 2459012 [TBL] [Abstract][Full Text] [Related]
11. [Initial trials give hope. Anticoagulants against cancer?]. Hiller E MMW Fortschr Med; 2003 Apr; 145(14):16. PubMed ID: 15072270 [No Abstract] [Full Text] [Related]
12. Antitumor and antimetastatic effect of warfarin and heparins. Bobek V; KovarÃk J Biomed Pharmacother; 2004 May; 58(4):213-9. PubMed ID: 15183845 [TBL] [Abstract][Full Text] [Related]
13. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy. Laufman H Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618 [No Abstract] [Full Text] [Related]
14. [Current trends in anticoagulant and thrombolytic therapy of thrombosis]. Gavrilov OK; Rachinskaia NA; Kaveshnikova BF Sov Med; 1975 Sep; (9):53-9. PubMed ID: 781864 [No Abstract] [Full Text] [Related]
15. [Cancer, hemostasis and coaguloactive drugs]. Nadiradze ISh Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281 [No Abstract] [Full Text] [Related]
16. Effect of fibrinolytic and antifibrinolytic therapy on the dissemination of experimental tumours. Rudenstam CM Bibl Anat; 1967; 9():418-24. PubMed ID: 4226503 [No Abstract] [Full Text] [Related]
17. [Effect of heparin on the metastasis of inoculated tumor in rats]. Yamaguchi S Med J Osaka Univ; 1972 Sep; 23(1):31-9. PubMed ID: 4265202 [No Abstract] [Full Text] [Related]